Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001705477-26-000003

Chief Financial Officer sold 4,442 shares at $45.43 ($201,787)

  • Chief Financial Officer acquired 10,937 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Nofi Michael · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-10 Exercise or conversion : show line 1 in the form +10,937 10,937 D
2026-11-10 Sale : show line 2 in the form −4,442 $45.43 $201,787 6,495 D
Open-market sales · 4,442 sh · avg $45.43 · $201,787

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-10 Exercise or conversion : show line 3 in the form Restricted Stock Units −10,937 32,813 D
Loading xslF345X06/primarydocument.xml…